MedicarePartD.guide

A non-government resource built from CMS public data

TYVASO DPI 32 ug Inhalant

Also known as Treprostinil. Coverage in Oregon and Washington (CMS PDP Region 30).

Not on any stand-alone Part D formulary in Oregon and Washington

None of the 10 stand-alone Part D (PDP) plans in CMS PDP Region 30 list this drug. On one of those plans the patient would pay the full retail price, or you would need a formulary exception.

23 Medicare Advantage plans in OR, WA do cover it

Medicare Advantage plans carry their own formularies, separate from stand-alone Part D. A patient on an MA-PD plan may have coverage even where no PDP lists the drug. OR: 4 plans · WA: 19 plans.

See coverage in all 39 regions →